South African Health Products Regulatory Authority
-
Africa’s first end-to-end mRNA facility secures SAHPRA approval
Afrigen Biologics has secured SAHPRA GMP certification for its Cape Town mRNA facility—the first end-to-end site in Africa authorised to manufacture investigational biologicals for Phase I/II trials. Discover how this milestone strengthens supply security, pandemic readiness and the WHO-MPP mRNA network.
-
Unregistered Semaglutide Tirzepatide recall: SAHPRA & SAPC seize products at Sentra Pharmacy
SAHPRA and the SAPC raided Sentra Pharmacy (Silverton, Pretoria) on 11 May 2026, seizing unregistered Semaglutide, Tirzepatide and combo GLP‑1/GIP injectables amid illegal API imports, poor sterility and no pharmacovigilance. See the enforcement steps, recall scope and risks for patients and prescribers.
